Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms

Journal of Neurochemistry

Volumn 125, Issue 3, 2013, Pages 373-385

  Avelar, Alicia J ^a,b   Juliano, Steven A ^a   Garris, Paul A ^a  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

degradation; exocytosis; rat; synthesis; voltammetry

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG TARGETING; ELECTROSTIMULATION; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS INHIBITION; RAT; UPREGULATION;

ALPHA-METHYLTYROSINE; AMPHETAMINES; ANIMALS; BASAL GANGLIA; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; MALE; MONOAMINE OXIDASE INHIBITORS; MULTIVARIATE ANALYSIS; PARGYLINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

RATTUS;

EID: 84876694795     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12197     Document Type: Article

References (63)

1. Aceto M. D., Botton I., Martin R., Levitt M., Bentley H. C., and, Speight P. T., (1970) Pharmacologic properties and mechanism of action of amfonelic acid. Eur. J. Pharmacol. 10, 344-354.
2. Anderson B. B., Chen G., Gutman D. A., and, Ewing A. G., (1998) Dopamine levels of two classes of vesicles are differentially depleted by amphetamine. Brain Res. 788, 294-301.
3. Brown J. M., Hanson G. R., and, Fleckenstein A. E., (2001) Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors. J. Pharmacol. Exp. Ther. 298, 1150-1153.
4. Carboni E., Imperato A., Perezzani L., and, Di Chiara G., (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28, 653-661.
5. Cass W. A., Gerhardt G. A., Mayfield R. D., Curella P., and, Zahniser N. R., (1992) Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J. Neurochem. 59, 259-266.
6. Chadchankar H., Ihalainen J., Tanila H., and, Yavich L., (2012) Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an alpha-synuclein-dependent mechanism. J. Pharmacol. Exp. Ther. 341, 484-492.
7. Cheer J. F., Aragona B. J., Heien M. L., Seipel A. T., Carelli R. M., and, Wightman R. M., (2007) Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 54, 237-244.
8. Chen G., and, Ewing A. G., (1995) Multiple classes of catecholamine vesicles observed during exocytosis from the Planorbis cell body. Brain Res. 701, 167-174.
9. Daberkow D. P., Brown H. D., Bunner K. D., Kraniotis S. A., Doellman M. A., Ragozino M. E., Garris P. A., and, Roitman M. F., (2013) Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J. Neurosci. 33, 452-463.
10. Di C. G., and, Imperato A., (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. U. S. A. 85, 5274-5278.
11. Everitt B. J., and, Robbins T. W., (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481-1489.
12. Ewing A. G., Bigelow J. C., and, Wightman R. M., (1983) Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 221, 169-171.
13. Fleckenstein A. E., Haughey H. M., Metzger R. R., Kokoshka J. M., Riddle E. L., Hanson J. E., Gibb J. W., and, Hanson G. R., (1999) Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur. J. Pharmacol. 382, 45-49.
14. Fleckenstein A. E., Volz T. J., Riddle E. L., Gibb J. W., and, Hanson G. R., (2007) New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681-698.
15. Garris P. A., and, Wightman R. M., (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14, 442-450.
16. Garris P. A., and, Wightman R. M., (1995) Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo. Synapse 20, 269-279.
17. Garris P. A., Ciolkowski E. L., and, Wightman R. M., (1994) Heterogeneity of evoked dopamine overflow within the striatal and striatoamygdaloid regions. Neuroscience 59, 417-427.
18. Garris P. A., Christensen J. R., Rebec G. V., and, Wightman R. M., (1997) Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J. Neurochem. 68, 152-161.
19. Greengard P., Valtorta F., Czernik A. J., and, Benfenati F., (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259, 780-785.
20. Heal D. J., Cheetham S. C., and, Smith S. L., (2009) The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57, 608-618.
21. Heien M. L., Phillips P. E., Stuber G. D., Seipel A. T., and, Wightman R. M., (2003) Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst. 128, 1413-1419.
22. Hyman S. E., (2005) Addiction: a disease of learning and memory. Am. J. Psychiatry 162, 1414-1422.
23. Ingram S. L., Prasad B. M., and, Amara S. G., (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5, 971-978.
24. Jones S. R., Garris P. A., and, Wightman R. M., (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274, 396-403.
25. Jones S. R., Gainetdinov R. R., Wightman R. M., and, Caron M. G., (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986.
26. Kile B. M., Guillot T. S., Venton B. J., Wetsel W. C., Augustine G. J., and, Wightman R. M., (2010) Synapsins differentially control dopamine and serotonin release. J. Neurosci. 30, 9762-9770.
27. Kuczenski R., (1975) Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase. Neuropharmacology 14, 1-10.
28. Kuczenski R., (1983) Biochemical actions of amphetamine and other stimulants, in Stimulants: Neurochemical, Behavioral and Clinical Perspectives (, Creese I., ed.), pp. 31-61. Raven Press, New York.
29. Kuczenski R., and, Segal D. S., (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 1085-1094.
30. Kuhr W. G., Ewing A. G., Near J. A., and, Wightman R. M., (1985) Amphetamine attenuates the stimulated release of dopamine in vivo. J. Pharmacol. Exp. Ther. 232, 388-394.
31. Kuhr W. G., Bigelow J. C., and, Wightman R. M., (1986) In vivo comparison of the regulation of releasable dopamine in the caudate nucleus and the nucleus accumbens of the rat brain. J. Neurosci. 6, 974-982.
32. Lee T. H., Balu R., Davidson C., and, Ellinwood E. H., (2001) Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. Synapse 41, 301-310.
33. Logman M. J., Budygin E. A., Gainetdinov R. R., and, Wightman R. M., (2000) Quantitation of in vivo measurements with carbon fiber microelectrodes. J. Neurosci. Methods 95, 95-102.
34. May L. J., and, Wightman R. M., (1989) Heterogeneity of stimulated dopamine overflow within rat striatum as observed with in vivo voltammetry. Brain Res. 487, 311-320.
35. May L. J., Kuhr W. G., and, Wightman R. M., (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J. Neurochem. 51, 1060-1069.
36. Michael D., Travis E. R., and, Wightman R. M., (1998) Color images for fast-scan CV measurements in biological systems. Anal. Chem. 70, 586A-592A.
37. Mundorf M. L., Hochstetler S. E., and, Wightman R. M., (1999) Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J. Neurochem. 73, 2397-2405.
38. Oleson E. B., Salek J., Bonin K. D., Jones S. R., and, Budygin E. A., (2009) Real-time voltammetric detection of cocaine-induced dopamine changes in the striatum of freely moving mice. Neurosci. Lett. 467, 144-146.
39. Patel J., Mooslehner K. A., Chan P. M., Emson P. C., and, Stamford J. A., (2003) Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J. Neurochem. 85, 898-910.
40. Paxinos G., and, Watson C., (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
41. Peacock J., and, Benca R. M., (2010) Narcolepsy: clinical features, co-morbidities & treatment. Indian J. Med. Res. 131, 338-349.
42. Pieribone V. A., Shupliakov O., Brodin L., Hilfiker-Rothenfluh S., Czernik A. J., and, Greengard P., (1995) Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375, 493-497.
43. Ramsson E. S., Covey D. P., Daberkow D. P., Litherland M. T., Juliano S. A., and, Garris P. A., (2011a) Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. J. Neurochem. 117, 937-948.
44. Ramsson E. S., Howard C. D., Covey D. P., and, Garris P. A., (2011b) High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. J. Neurochem. 119, 1162-1172.
45. Riddle E. L., Topham M. K., Haycock J. W., Hanson G. R., and, Fleckenstein A. E., (2002) Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur. J. Pharmacol. 449, 71-74.
46. Riddle E. L., Hanson G. R., and, Fleckenstein A. E., (2007) Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. Eur. J. Pharmacol. 571, 25-28.
47. Ritz M. C., Lamb R. J., Goldberg S. R., and, Kuhar M. J., (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
48. Rizzoli S. O., and, Betz W. J., (2005) Synaptic vesicle pools. Nat. Rev. Neurosci. 6, 57-69.
49. Robinson D. L., and, Wightman R. M., (2004) Nomifensine amplifies subsecond dopamine signals in the ventral striatum of freely-moving rats. J. Neurochem. 90, 894-903.
50. Robinson D. L., and, Wightman R. M., (2007) Rapid dopamine release in freely moving rats, in Electrochemical Methods for Neuroscience (, Michael A. C., and, Borland L. M., eds), pp. 17-34. CRC Press, Boca Raton.
51. Schmitz Y., Lee C. J., Schmauss C., Gonon F., and, Sulzer D., (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J. Neurosci. 21, 5916-5924.
52. Scorza M. C., Carrau C., Silveira R., Zapata-Torres G., Cassels B. K., and, Reyes-Parada M., (1997) Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships. Biochem. Pharmacol. 54, 1361-1369.
53. Seiden L. S., Sabol K. E., and, Ricaurte G. A., (1993) Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33, 639-677.
54. Shore P. A., (1976) Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J. Pharm. Pharmacol. 28, 855-857.
55. Stuber G. D., Wightman R. M., and, Carelli R. M., (2005) Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron 46, 661-669.
56. Sulzer D., (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628-649.
57. Venton B. J., Seipel A. T., Phillips P. E., Wetsel W. C., Gitler D., Greengard P., Augustine G. J., and, Wightman R. M., (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J. Neurosci. 26, 3206-3209.
58. Volz T. J., Farnsworth S. J., King J. L., Riddle E. L., Hanson G. R., and, Fleckenstein A. E., (2007) Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J. Pharmacol. Exp. Ther. 323, 738-745.
59. Volz T. J., Farnsworth S. J., Rowley S. D., Hanson G. R., and, Fleckenstein A. E., (2008) Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors. J. Pharmacol. Exp. Ther. 327, 161-167.
60. Wanat M. J., Willuhn I., Clark J. J., and, Phillips P. E., (2009) Phasic dopamine release in appetitive behaviors and drug addiction. Curr. Drug Abuse Rev. 2, 195-213.
61. Wightman R. M., Amatore C., Engstrom R. C., Hale P. D., Kristensen E. W., Kuhr W. G., and, May L. J., (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25, 513-523.
62. Wu Q., Reith M. E., Kuhar M. J., Carroll F. I., and, Garris P. A., (2001a) Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J. Neurosci. 21, 6338-6347.
63. Wu Q., Reith M. E., Wightman R. M., Kawagoe K. T., and, Garris P. A., (2001b) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112, 119-133.